438 related articles for article (PubMed ID: 23715538)
1. Induced pluripotent stem cells in medicine and biology.
Takahashi K; Yamanaka S
Development; 2013 Jun; 140(12):2457-61. PubMed ID: 23715538
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
Das AK; Pal R
J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
[TBL] [Abstract][Full Text] [Related]
3. iPSCs from cancer cells: challenges and opportunities.
Ramos-Mejia V; Fraga MF; Menendez P
Trends Mol Med; 2012 May; 18(5):245-7. PubMed ID: 22521522
[TBL] [Abstract][Full Text] [Related]
4. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
Hussein SM; Nagy AA
Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced pluripotent stem cells from somatic cells.
Sohn YD; Han JW; Yoon YS
Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
[TBL] [Abstract][Full Text] [Related]
6. Role of mass spectrometry-based proteomics in the study of cellular reprogramming and induced pluripotent stem cells.
Benevento M; Munoz J
Expert Rev Proteomics; 2012 Aug; 9(4):379-99. PubMed ID: 22967076
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming of somatic cells.
Rajasingh J
Prog Mol Biol Transl Sci; 2012; 111():51-82. PubMed ID: 22917226
[TBL] [Abstract][Full Text] [Related]
8. Generation and genetic modification of induced pluripotent stem cells.
Schambach A; Cantz T; Baum C; Cathomen T
Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
[TBL] [Abstract][Full Text] [Related]
9. Cell fate plug and play: direct reprogramming and induced pluripotency.
Chambers SM; Studer L
Cell; 2011 Jun; 145(6):827-30. PubMed ID: 21663788
[TBL] [Abstract][Full Text] [Related]
10. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
11. Advances in cell lineage reprogramming.
Zhou J; Yue W; Pei X
Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
[TBL] [Abstract][Full Text] [Related]
12. Delivery of reprogramming factors into fibroblasts for generation of non-genetic induced pluripotent stem cells using a cationic bolaamphiphile as a non-viral vector.
Khan M; Narayanan K; Lu H; Choo Y; Du C; Wiradharma N; Yang YY; Wan AC
Biomaterials; 2013 Jul; 34(21):5336-43. PubMed ID: 23601660
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor-induced enhancer modulations during cell fate conversions.
van Oevelen C; Kallin EM; Graf T
Curr Opin Genet Dev; 2013 Oct; 23(5):562-7. PubMed ID: 23968684
[TBL] [Abstract][Full Text] [Related]
14. Exploiting pluripotency for therapeutic gain.
Deng W
Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
[TBL] [Abstract][Full Text] [Related]
15. Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells.
Pournasr B; Khaloughi K; Salekdeh GH; Totonchi M; Shahbazi E; Baharvand H
Stem Cells; 2011 Dec; 29(12):1933-41. PubMed ID: 21997905
[TBL] [Abstract][Full Text] [Related]
16. A plethora of human pluripotent stem cells.
Gao L; Thilakavathy K; Nordin N
Cell Biol Int; 2013 Sep; 37(9):875-87. PubMed ID: 23619972
[TBL] [Abstract][Full Text] [Related]
17. [Genetic Cell Reprogramming: A New Technology for Basic Research and Applied Usage].
Bogomazova AN; Vassina EM; Kiselev SI; Lagarkova MA; Lebedeva OS; Nekrasov ED; Panova AV; Philonenko ES; Khomyakova EA; Tskhovrebova LV; Chestkov IV; Shutova MV
Genetika; 2015 Apr; 51(4):466-78. PubMed ID: 26087622
[TBL] [Abstract][Full Text] [Related]
18. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
Galach M; Utikal J
Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
[TBL] [Abstract][Full Text] [Related]
19. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
20. Present and future challenges of induced pluripotent stem cells.
Ohnuki M; Takahashi K
Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
